4//SEC Filing
Litchfield Caroline 4
Accession 0001127602-23-014238
CIK 0000310158other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 4:07 PM ET
Size
8.5 KB
Accession
0001127602-23-014238
Insider Transaction Report
Form 4
Litchfield Caroline
EVP & CFO
Transactions
- Exercise/Conversion
Common Stock
2023-05-01$115.47/sh+866$99,997→ 32,118.269 total - Tax Payment
Common Stock
2023-05-01$115.47/sh−427$49,306→ 31,691.269 total - Exercise/Conversion
Restricted Stock Unit
2023-05-01−866→ 0 totalFrom: 2021-05-01Exp: 2023-05-01→ Common Stock (866 underlying)
Footnotes (3)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F3]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeother
Related Parties
1- filerCIK 0001854928
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 4:07 PM ET
- Size
- 8.5 KB